Signal active
Bio
Eric Heil is the current Interim CEO and Chairman of ProJenX. He previously worked at Health Quality Partners (HQP) as a SVP, Global Growth and Opportunity. Eric Heil attended The Wharton School.
Location
Doylestown, Pennsylvania, United States, North America
Social
Primary Organization
2021
1-10
Biotechnology, Health Care, Biopharma, Therapeutics
Jobs history
1
ProJenX
Interim CEO, Board Member & Chairman
2021 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Eric Heil is the Interim CEO, Board Member & Chairman at ProJenX, based in United States, North America. With a background in Biotechnology, Eric Heil has a rich history of leadership and innovation. Eric Heil studied BE Systems Engineering, Healthcare Systems @ University of Pennsylvania. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
1
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Jul 01, 2012 | Adynxx | Venture Round - Adynxx | Domain Associates | 2.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.